A randomized double-blind placebo-controlled study on nadroparin for prophylaxis of thromboembolic events in cancer patients receiving chemotherapy: The PROTECHT Study

Pas encore traduit Pas encore traduit
Catégorie Primary study
JournalBlood
Year 2008

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
This article is part of the following matrixes of evidence:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: a0a9ec6ba05978e1d090ca9ea7fb1c541e45a197
First added on: Mar 14, 2016